Works matching IS 14644096 AND DT 2015 AND VI 116 AND IP 6


Results: 29
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    15
    16
    17
    18
    19
    20

    Determination of optimal drug dose and light dose index to achieve minimally invasive focal ablation of localised prostate cancer using WST11-vascular-targeted photodynamic ( VTP) therapy.

    Published in:
    BJU International, 2015, v. 116, n. 6, p. 888, doi. 10.1111/bju.12816
    By:
    • Moore, Caroline M.;
    • Azzouzi, Abel‐Rahmene;
    • Barret, Eric;
    • Villers, Arnauld;
    • Muir, Gordon H.;
    • Barber, Neil J.;
    • Bott, Simon;
    • Trachtenberg, John;
    • Arumainayagam, Nimalan;
    • Gaillac, Bertrand;
    • Allen, Clare;
    • Schertz, Avigdor;
    • Emberton, Mark
    Publication type:
    Article
    21
    22
    24
    25
    26
    27
    28

    Final quality of life and safety data for patients with metastatic castration-resistant prostate cancer treated with cabazitaxel in the UK Early Access Programme (EAP) ( NCT01254279).

    Published in:
    BJU International, 2015, v. 116, n. 6, p. 880, doi. 10.1111/bju.13069
    By:
    • Bahl, Amit;
    • Masson, Susan;
    • Malik, Zafar;
    • Birtle, Alison J.;
    • Sundar, Santhanam;
    • Jones, Rob J.;
    • James, Nicholas D.;
    • Mason, Malcolm D.;
    • Kumar, Satish;
    • Bottomley, David;
    • Lydon, Anna;
    • Chowdhury, Simon;
    • Wylie, James;
    • Bono, Johann S.
    Publication type:
    Article
    29